GHRP-6¶
Identification¶
| Property | Value |
|---|---|
| CAS Number | 87616-84-0 |
| Molecular Formula | C₄₆H₅₆N₁₂O₆ |
| Molecular Weight | ~873.0 Da |
| Sequence | His-D-Trp-Ala-Trp-D-Phe-Lys-NH₂ |
| Amino Acid Count | 6 (D-Trp², D-Phe⁵) |
| Appearance | White to off-white lyophilized powder |
| Purity Standard | ≥99% by HPLC |
| Solubility | Soluble in sterile or bacteriostatic water |
| Storage | 2–8°C, desiccated, protect from light |
Category: Muscle Growth
Catalog SKU: PSH-GHRP6-5MG
Research Background¶
GHRP-6 is the prototypical synthetic ghrelin receptor agonist — and the most orexigenic member of the GHRP family. Its hexapeptide sequence (His-D-Trp-Ala-Trp-D-Phe-Lys-NH₂) closely mimics the N-terminal active core of ghrelin, producing potent activation of both the GH-releasing and appetite-stimulating arms of GHS-R1a signaling.
Key Mechanisms¶
| Mechanism | Details |
|---|---|
| GHS-R1a Agonism | Potent ghrelin receptor activation → GH release + appetite signaling |
| NPY/AgRP Activation | GHS-R activation in hypothalamic arcuate nucleus → NPY/AgRP neurons → hunger |
| GI Motility | Ghrelin mimetic activity on enteric neurons → gastric emptying and motility |
Research Focus Areas¶
GH Release¶
Potent pituitary GH secretion via ghrelin receptor activation
Appetite Research¶
Strong orexigenic (hunger-promoting) signaling — ghrelin pathway studies
Gastric Motility¶
Ghrelin-mediated GI motility and gastric emptying research
Body Composition¶
GH/IGF-1 mediated anabolic effects with appetite co-stimulation
Available Configurations¶
| Configuration | Content | Best For |
|---|---|---|
| Standard Kit | 5 mg × 10 vials | Ghrelin pathway research; evaluation |
| Bulk Kit | 10 mg × 10 vials | Chronic protocols; repeat orders |
| Custom | Custom mg × custom vials | OEM; private-label |
Tiered Wholesale Pricing¶
| Volume | Discount | For |
|---|---|---|
| 1 kit | List price | Evaluation; competitive analysis |
| 5+ kits | 10% off | Initial portfolio expansion |
| 20+ kits | 20% off | Mid-size distributors |
| 50+ kits | 30% off | Regional distributors |
Quality Specifications¶
| Parameter | Method | Criterion |
|---|---|---|
| Purity | HPLC at 214 nm, C18 column | ≥99.0% peak area |
| Identity (MW) | ESI-MS | ~873.0 ± 1.0 Da |
| Appearance | Visual inspection | White to off-white powder |
| Chiral Purity | Chiral HPLC | D-Trp², D-Phe⁵ verified |
| Residual Moisture | Karl Fischer | ≤3% |
Frequently Asked Questions¶
Q1: Why does GHRP-6 increase hunger so strongly?¶
GHRP-6 is the closest structural mimetic to ghrelin's N-terminal active core. Its activation of GHS-R1a in the hypothalamic arcuate nucleus strongly stimulates NPY/AgRP neurons — the most potent orexigenic neurons in the brain.
Q2: How does GHRP-6 compare to GHRP-2?¶
Both are potent GHS-R1a agonists, but GHRP-6 produces stronger hunger signaling due to closer structural homology to ghrelin. GHRP-2 has modifications (D-Ala¹, D-2-Nal²) that shift toward purer GH release with less appetite stimulation.
Q3: Is GHRP-6 suitable for all GH research?¶
It depends on protocol. GHRP-6 is the tool of choice when studying ghrelin's dual GH-releasing and appetite-stimulating effects. When appetite is a confounding variable, Ipamorelin (minimal hunger) or GHRP-2 (moderate hunger) should be considered.
Q4: What is the structural basis of GHRP-6 activity?¶
D-Trp² and D-Phe⁵ residues are critical for GHS-R1a binding and stability. His¹ mimics ghrelin's N-terminal serine-3 acylation site. Together these enable nanomolar potency while resisting degradation.
Q5: How should GHRP-6 be stored?¶
Lyophilized: 2–8°C, desiccated, 24-month stability. Reconstitute, aliquot, store at -20°C. D-amino acid modifications provide good solution stability. Protect from freeze-thaw cycles.
Key Research References¶
| Reference | PMID | Key Finding |
|---|---|---|
| Bowers CY et al. "On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone." Endocrinology. 1984;114(5):1537–1545. | 6714155 | Original characterization of GHRP-6 as the prototypical synthetic ghrelin receptor agonist; GHS-R1a agonism as a new mechanism for GH release |
| Kojima M et al. "Ghrelin is a growth-hormone-releasing acylated peptide from stomach." Nature. 1999;402(6762):656–660. | 10604470 | Discovery of ghrelin as the endogenous GHS-R ligand; provided structural basis for GHRP-6's orexigenic and GH-releasing activities |
Stability & Storage¶
| Condition | Degradation Profile |
|---|---|
| Lyophilized Storage | 24 months at 2–8°C in desiccated environment, protect from light |
| D-Amino Acid Stability | D-Trp² and D-Phe⁵ provide resistance to enzymatic degradation; extended solution stability vs all-L peptides |
| Neutral pH (6.0–7.5) | Stable; recommended for reconstitution in sterile or bacteriostatic water |
| Reconstituted Solution | 24 h at 2–8°C; aliquot and freeze at −20°C. D-amino acid backbone provides good solution stability. Avoid freeze-thaw cycles |
Source & Purchase¶
For research-grade GHRP 6 and related compounds in this category, visit the PeptideSourceHub category page for bulk pricing and available specifications.
Browse GHRP 6 & Related Products →
Related Products¶
| Product | Link |
|---|---|
| GHRP-2 (Pralmorelin) | ghrp-2.md — Potent ghrelin receptor agonist |
| Ipamorelin | ipamorelin.md — Selective GHS-R1a agonist |
| CJC-1295 (no DAC) | cjc-1295-no-dac.md — Pulsatile GHRH analogue |
| HGH (Somatropin) | hgh.md — 191-aa human growth hormone |